Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T06:45:31.006Z Has data issue: false hasContentIssue false

Cannabis Policy Innovations and the Challenges for EU Coordination in Drug Policy

Published online by Cambridge University Press:  12 October 2020

Constanza Sánchez-Avilés*
Affiliation:
Director of Law, Policy and Human Rights, ICEERS.
Rights & Permissions [Opens in a new window]

Extract

In the past decades, Europe has been the site of multiple drug policy innovations and cannabis policy experimentation. Most of the policy reforms in this area are taking place at the national and subnational levels. They have not resulted from agreements or harmonization initiatives at the EU level, but rather from bottom-up adoption of cannabis policies and practices that deviate from punitive approaches. Cannabis regulation has been only marginally debated by European institutions and is not discussed in depth in any EU document. On the one hand, the diversity of European drug policies is a positive development: it serves as a policy laboratory and reflects adaptations to local contexts in light of drug market-related challenges. On the other hand, a greater EU consensus would be helpful for policy coordination and international engagement.

Information

Type
Essay
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Constanza Sánchez-Avilés 2020